<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><description>医药行业一致性评价工作在如火如荼的进行中，作为行业的一份子，愿本愚公之念，出蝼蚁 之力，献寸光之策。</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 20 May 2021 23:29:00 +0800</pubDate><image><url>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</url><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>这些年销数十亿的多肽重磅，你熟悉哪几个？</title><link>https://mp.weixin.qq.com/s/WcJlc72QNxVBHeNR790YRA</link><description></description><content:encoded><![CDATA[这些年销数十亿的多肽重磅，你熟悉哪几个？]]></content:encoded><pubDate>Thu, 20 May 2021 21:37:51 +0800</pubDate></item><item><title>【官方图解】“数”说十三五 · 药品安全这五年</title><link>https://mp.weixin.qq.com/s/z4v7yCOHGrLb_z-SXmk3kA</link><description></description><content:encoded><![CDATA[【官方图解】“数”说十三五 · 药品安全这五年]]></content:encoded><pubDate>Thu, 20 May 2021 21:37:51 +0800</pubDate></item><item><title>102个未过评药，暂停采购！</title><link>https://mp.weixin.qq.com/s/Ut6ktX9GWXWMgxU0qFs_-A</link><description></description><content:encoded><![CDATA[102个未过评药，暂停采购！]]></content:encoded><pubDate>Thu, 20 May 2021 21:37:51 +0800</pubDate></item><item><title>广州API：药春秋（佰瑞医药）10.2馆N31</title><link>https://mp.weixin.qq.com/s/v9qwVEct0mXKJJAGl2tPHg</link><description></description><content:encoded><![CDATA[广州API：药春秋（佰瑞医药）10.2馆N31]]></content:encoded><pubDate>Thu, 20 May 2021 21:37:51 +0800</pubDate></item><item><title>品种最多、范围最广、体量最大的联盟集采来袭！</title><link>https://mp.weixin.qq.com/s/ay3clO9cvCdisbmW_HJDFw</link><description></description><content:encoded><![CDATA[品种最多、范围最广、体量最大的联盟集采来袭！]]></content:encoded><pubDate>Thu, 20 May 2021 21:37:51 +0800</pubDate></item><item><title>（2021.5.19）最新一致性评价名单，4品种过评决出首家…</title><link>https://mp.weixin.qq.com/s/s5tf_diWWrEOep9hrt-S3w</link><description></description><content:encoded><![CDATA[（2021.5.19）最新一致性评价名单，4品种过评决出首家…]]></content:encoded><pubDate>Wed, 19 May 2021 21:41:03 +0800</pubDate></item><item><title>省际联盟集采“蜂拥而至”，主力军-注射剂占比均超七成</title><link>https://mp.weixin.qq.com/s/c4B-6MSp4m8Ae_gtoWjl1g</link><description></description><content:encoded><![CDATA[省际联盟集采“蜂拥而至”，主力军-注射剂占比均超七成]]></content:encoded><pubDate>Wed, 19 May 2021 21:41:03 +0800</pubDate></item><item><title>一大批药品，不许卖了！</title><link>https://mp.weixin.qq.com/s/N4fcEMVvCTkSPnshKOk6eQ</link><description></description><content:encoded><![CDATA[一大批药品，不许卖了！]]></content:encoded><pubDate>Wed, 19 May 2021 21:41:03 +0800</pubDate></item><item><title>基药目录，最新消息流出！</title><link>https://mp.weixin.qq.com/s/DEv4GxsI8uNNkQ8Pc8hkNg</link><description></description><content:encoded><![CDATA[基药目录，最新消息流出！]]></content:encoded><pubDate>Wed, 19 May 2021 21:41:03 +0800</pubDate></item><item><title>2021年一季度仿制药成绩单：齐鲁摘下桂冠！</title><link>https://mp.weixin.qq.com/s/7DtJOg505-394bXZoho4hg</link><description></description><content:encoded><![CDATA[2021年一季度仿制药成绩单：齐鲁摘下桂冠！]]></content:encoded><pubDate>Tue, 18 May 2021 21:37:33 +0800</pubDate></item><item><title>38个大品种，药价联动下调，最高降幅达61.45%！</title><link>https://mp.weixin.qq.com/s/j01wgtb3Fkqfy4GIotVyxQ</link><description></description><content:encoded><![CDATA[38个大品种，药价联动下调，最高降幅达61.45%！]]></content:encoded><pubDate>Tue, 18 May 2021 21:37:33 +0800</pubDate></item><item><title>广州API，5月26-28日，佰瑞医药，10.2馆N31</title><link>https://mp.weixin.qq.com/s/z-H6afLsGRZ999SttUq-DA</link><description></description><content:encoded><![CDATA[广州API，5月26-28日，佰瑞医药，10.2馆N31]]></content:encoded><pubDate>Tue, 18 May 2021 21:37:33 +0800</pubDate></item><item><title>一文初识丨药品从研发到上市的全过程</title><link>https://mp.weixin.qq.com/s/U_1NyNbH8JVDEIqpN13ZLw</link><description></description><content:encoded><![CDATA[一文初识丨药品从研发到上市的全过程]]></content:encoded><pubDate>Tue, 18 May 2021 21:37:33 +0800</pubDate></item><item><title>违反药品竞争法，严罚2.4亿元！</title><link>https://mp.weixin.qq.com/s/mgwwUq4dROQZE1dBMALy4A</link><description></description><content:encoded><![CDATA[违反药品竞争法，严罚2.4亿元！]]></content:encoded><pubDate>Mon, 17 May 2021 21:42:14 +0800</pubDate></item><item><title>最新过评名单：38品规迎喜讯，5国采品种格局生变</title><link>https://mp.weixin.qq.com/s/eat8dsliuXBNlX03lihUKw</link><description></description><content:encoded><![CDATA[最新过评名单：38品规迎喜讯，5国采品种格局生变]]></content:encoded><pubDate>Mon, 17 May 2021 21:42:14 +0800</pubDate></item><item><title>刚刚！第四十三批参比目录公示，44个审议不通过...</title><link>https://mp.weixin.qq.com/s/94BENPwYgfZuT0aCcPPBSw</link><description></description><content:encoded><![CDATA[刚刚！第四十三批参比目录公示，44个审议不通过...]]></content:encoded><pubDate>Mon, 17 May 2021 21:42:14 +0800</pubDate></item><item><title>这些注射剂，需最低价挂网！</title><link>https://mp.weixin.qq.com/s/P6T_94MjFMyEo7p7lSnYog</link><description></description><content:encoded><![CDATA[这些注射剂，需最低价挂网！]]></content:encoded><pubDate>Mon, 17 May 2021 21:42:14 +0800</pubDate></item><item><title>制剂：“我刚审到一半，你（原料）跟我说有变更？！”</title><link>https://mp.weixin.qq.com/s/s5Om3ermT45ucU5uyxPMsw</link><description></description><content:encoded><![CDATA[制剂：“我刚审到一半，你（原料）跟我说有变更？！”]]></content:encoded><pubDate>Sat, 15 May 2021 21:28:31 +0800</pubDate></item><item><title>4月一致性评价：集采助力，过评再现“暴涨”…</title><link>https://mp.weixin.qq.com/s/63TWKDmAtWaVAjvLTfiZIQ</link><description></description><content:encoded><![CDATA[4月一致性评价：集采助力，过评再现“暴涨”…]]></content:encoded><pubDate>Fri, 14 May 2021 21:41:09 +0800</pubDate></item><item><title>抗青光眼市场，前列素类药独占鳌头，新疗法优势十足！</title><link>https://mp.weixin.qq.com/s/vjyArre_bH5c4mQHOlsnNw</link><description></description><content:encoded><![CDATA[抗青光眼市场，前列素类药独占鳌头，新疗法优势十足！]]></content:encoded><pubDate>Fri, 14 May 2021 21:41:09 +0800</pubDate></item></channel></rss>